跳至主要内容
临床试验/KCT0007947
KCT0007947招募中未知

Clinical efficacy analysis of drug use tigecycline for re-creation of antimicrobial agents for treatment of Scrub typhus.

Inha University Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Among inpatients 19 years of age or older who have a fever of 37.5°C or higher (tympanic temperature measurement standard), rash, or crusts suspected of tsutsugamushi, who voluntarily decided to participate in the study
  • 2. Patient is diagnosed with tsutsugamushi disease by department of infectious disease specialist
  • 3. After hearing and fully understanding the detailed explanation of this clinical study, a person who voluntarily decides to participate and agrees in writing to abide by the precautions

排除标准

  • 1. Exclusion complications: Patients with severe complications such as respiratory distress pneumonia, encephalitis (Investigator decides on final exclusion)
  • 2. Chronic renal dysfunction patient
  • 3. Patient with a body weight of <45kg
  • 4. Immunocompromised patients: Administration of glucocorticoid and/or immunoglobulins for long-term
  • 5. Pregnant woman
  • 6. For both male and female patients, the patient and his or her partner of childbearing
  • potential who does not agree to use a highly effective or medically acceptable methods of
  • contraception during the course of the study and for 3 months following discontinuation of study drug as specified below:
  • * IUD (Intrauterinedevice), Barrier contraception that must include spermicide (for women's contraceptive diaphragm/vaginal sponge sponge/cervical cap) and double-blocking method (excluding simultaneous use of male and female condoms) with male condom use, infertility Procedures (vasectomy, vasectomy, tubal ligation, etc.)
  • 7. Unable to take medications by mouth
  • 8. Received any anti-rickettsia drug (including rifampin, chloramphenicol, macrolide, quinolone and tetracycline)
  • 9. Patients with shock or multiple organ failure that require vasopressors/vasoconstrictors, patients with reduced consciousness, patients with respiratory failure that require mechanical ventilation, patients with renal failure requiring hemodialysis
  • 10. Diagnosed with a disease other than tsutsugamushi

研究者

相似试验

Clinical efficacy analysis of drug use tigecycline... | 临床试验